ABI
DNDN

Adamant Biomedical Investments’s DENDREON CORPORATION DNDN Stock Holding History

Adamant Biomedical Investments’s Portfolio DNDN Stock Details DNDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50,000
Closed -$72K – 108
2014
Q3 		$72K Buy
+50,000
New +$72K 0.02% 95